Dr. Lee-Ling Lim is Associate Professor of Medicine, UM and Head of the Diabetes Care Unit, University of Malaya Medical Centre. As a clinician-scientist, her major areas of interest include cardiometabolic medicine and intergenerational diabetes with translational and implementation science components. 

Dr. Lim sits on the Working Groups of The Lancet Commission on Diabetes and the American Diabetes Association/European Association for the Study of Diabetes (ADA/EASD) Precision Medicine in Diabetes Initiative, who provide authoritative resources in tackling the global diabetes epidemic. She recognizes that every person with diabetes and non-communicable disease (NCD) is unique and warrants personalized care. To revolutionize health care, Dr. Lim aims to advance the implementation of Precision Medicine in Diabetes and NCD, taking into account differences in clinical presentation, genes, and lifestyles in Malaysian populations. These have led to several collaborations with the USA, UK, and other Asian countries. She has published in numerous high-impact journals including The Lancet, Nature, Diabetes Care, and Science Bulletin. 

Dr. Lim has received several awards including the World’s Top 2% Scientists by Stanford University for 2 consecutive years in 2022 and 2023, the EFSD Albert Renold Fellowship, the USA Endocrine Society Outstanding Abstract Award, and a scholarship funded by the USA NIH National Institute of General Medical Sciences for training in statistical genetics at the University of Washington, USA.

She is an Editorial Board Member of several Tier 1 Web of Science-indexed journals (BMC Medicine, Diabetes/Metabolism Research & Reviews, and Diabetes & Metabolism). Dr. Lim is an article reviewer for 28 leading academic journals including the European Heart Journal, Annals of Internal Medicine, Endocrine Reviews, PLoS Medicine, and European Journal of Preventive Cardiology.